【問題】PIONEER AF-PCI ?推薦回答
關於「PIONEER AF-PCI」標籤,搜尋引擎有相關的訊息討論:
PIONEER AF-PCI - Wiki Journal Club。
2017年12月3日 · Among patients with nonvalvular AF undergoing PCI with stent placement, does low-dose rivaroxaban plus either single or dual antiplatelet ...: 。
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated ...。
2018年7月30日 · In fact, results of the PIONEER AF-PCI and RE-DUAL PCI trials showed ... of Medicine–Jacksonville, 655 W 8th St, Jacksonville, FL 32209.: tw | tw。
From WOEST to AUGUSTUS: a review of safety and efficacy of triple ...。
Atrial fibrillation patients undergoing PCI are at increased risk of bleeding and ischemic ... The PIONEER AF-PCI trial had 52% patients with ACS (6).。
PIONEER AF-PCI: Rivaroxaban Plus P2Y12 Inhibitor or DAPT in ...。
2016年11月14日 · ... outcomes in patients with non-valvular atrial fibrillation (AFib), according to the results of the PIONEER AF-PCI Trial presented Nov.: 。
圖片全部顯示。
A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039。
... BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI) ...: 。
2017 ESC focused update on dual antiplatelet therapy in coronary ...。
PIONEER AF-PCI. Rivaroxaban and a dose- adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous ...。
2018 European Heart Rhythm Association Practical Guide on the ...。
2018年3月19日 · However, neither of the rivaroxaban doses in PIONEER AF-PCI (15 mg/10 mg ... FL. ,. Lutsey. PL. Prospective study of oral anticoagulants and ...。
[PIONEER AF-PCI trial] - PubMed。
The approach to patients with an indication for oral anticoagulation (OAC) for atrial fibrillation (AF) who undergo coronary stenting and thus need dual ...: 。
Antithrombotic Therapy for Percutaneous Cardiovascular Interventions。
The PIONEER AF-PCI was the first to study this scenario and randomized 2124 patients with ... G.L.: Conceived the review, G.M.-G.: Conceived the review, ...
常見PIONEER AF-PCI問答
延伸文章資訊The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
In this double-blind, placebo-controlled trial, we randomly assigned 15,526 patients with a recen...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...
The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
In this double-blind, placebo-controlled trial, we randomly assigned 15,526 patients with a recen...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...